title: Classical complement pathway activation in immune thrombocytopenia purpura: inhibition by a novel C1s inhibitor.
authors: Memorial Sloan Kettering Cancer Center, New York, NY, USA. peersche@mskcc.org.|Weill Medical College of Cornell University, New York, NY, USA. peersche@mskcc.org.
authors: Ellinor I B
authors: EI
authors: Peerschke
authors: True North Therapeutics, Inc., South San Francisco, CA, USA.
authors: Sandip
authors: S
authors: Panicker
authors: Weill Medical College of Cornell University, New York, NY, USA.
authors: James
authors: J
authors: Bussel
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000818:Animals; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000139:chemically induced; D002648:Child; D003167:Complement Activation / Q000187:drug effects / Q000276:immunology*; D003171:Complement Pathway, Classical / Q000187:drug effects*; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal
keywords: C1s inhibition; complement; immune thrombocytopenia purpura